Lyrica — 300MG, Capsule, bottle of 90 capsules

Lyrica — 300MG, Capsule, bottle of 90 capsules

Lyrica (PREGABALIN) is a capsule for oral use. LYRICA is indicated for: • Management of neuropathic pain associated with diabetic peripheral neuropathy • Management of postherpetic neuralgia • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older • Management of fibromyalgia • Management of neuropathic pain associated with spinal cord injury LYRICA is indicated for: • Neuropathic pain associated with diabetic peripheral neuropathy (DPN) ( 1 ) • Postherpetic neuralgia (PHN) ( 1 ) • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older ( 1 ) • Fibromyalgia ( 1 ) • Neuropathic pain associated with spinal cord injury ( 1 )

• Active ingredient or product type: PREGABALIN
• Strength/concentration: 300MG
• Dosage form and route: Capsule, Oral
• Exact package presentation: bottle of 90 capsules
• NDC/item number: 0071-1018-68
• Manufacturer: PFIZER PHARM
• Storage/handling: Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) (see USP Controlled Room Temperature).
• Status: Rx only

Important safety information: • Angioedema (e.g., swelling of the throat, head and neck) can occur, and may be associated with life-threatening respiratory compromise requiring emergency treatment.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.